Newsfile Corp
19 Nov 2026, 02:25 UTC · 1h ago
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX
Impact · against what's priced in
The announcement of a lead plaintiff deadline for a securities class action against Tenax Therapeutics creates potential future liabilities for cash reserves and EPS. While the litigation itself is the primary driver, the specific December 28 deadline provides a concrete timeline for the consolidation of claims.
- TENX−0.30
No priced-in read yet





